Stifel analyst Bradley Canino reiterated a Hold rating and $3.00 price target on ALX Oncology (NASDAQ: ALXO).The analyst said, "ALXO’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE